Avoiding propofol injection pain in children: a prospective, randomized, double-blinded, placebo-controlled study

A Rochette1, A F Hocquet, C Dadure

  • 1Department of Anaesthesia and Intensive Care A, Hôpital Lapeyronie, Montpellier, France. a-rochette@chu-montpellier.fr

Insights

A new propofol emulsion using medium-chain/long-chain triglycerides (MCT/LCT) significantly reduced injection pain in preschool children. Combining this new emulsion with lidocaine virtually eliminated pain, improving pediatric anesthesia.

Area of Science:

  • Anesthesiology
  • Pediatric Pharmacology
  • Pain Management

Background:

  • Pain on injection is a significant limitation for propofol use in pediatric patients.
  • Lidocaine is commonly combined with propofol to mitigate injection pain.
  • A novel medium-chain/long-chain triglyceride (MCT/LCT) propofol emulsion has shown reduced pain in adults, but its efficacy in preschool children is unknown.

Purpose of the Study:

  • To evaluate the injection pain associated with a new MCT/LCT propofol emulsion compared to standard LCT propofol in preschool children.
  • To assess the effect of lidocaine when combined with either propofol emulsion on injection pain.

Main Methods:

  • A prospective, randomized, double-blinded, placebo-controlled study involving 160 children under 7 years old.
  • Participants received either LCT-propofol or MCT/LCT-propofol with either lidocaine or saline.
  • Pain was assessed using a 0-6 scale based on verbal and motor reactions during injection.

Main Results:

  • Both propofol emulsions showed reduced pain scores compared to LCT-propofol with saline (P<0.001).
  • The MCT/LCT-propofol combined with lidocaine group exhibited the least pain (P<0.001).
  • Painless injections (score 0-2) occurred in 92.5% of patients receiving MCT/LCT-propofol with lidocaine, versus 41-77% in other groups (P<0.001).

Conclusions:

  • The MCT/LCT propofol emulsion significantly reduces injection pain in preschool children compared to standard LCT propofol.
  • The addition of lidocaine to the MCT/LCT propofol emulsion further decreases pain, effectively eliminating it during injection.
Abstract